According to Mordor Intelligence, theglobal exosomesmarketis valued at USD 0.71 billion in 2025 and is projected to surpass USD 2.21 billion by 2030, at a 25.5% CAGR during 2025-2030. The market iswitnessingstrong momentum due to rapid advancements in exosome isolation, characterization, and engineering technologies, which are transforming their role in precision medicine, oncology, regenerative therapies, and liquid biopsy innovations.
https://mma.prnewswire.com/media/2746908/Mordor_Intelligence_Logo.jpg
The expanding volume of cancer research, increased adoption of liquid biopsy techniques, and rising interest in cell-free therapeutic delivery systems are further accelerating market adoption across clinical and research ecosystems.
EmergingMarketTrends
Rise in Exosome-Based Diagnostics
The global shift toward minimally invasive diagnostic tools has significantly boosted the development of exosome-powered assays. These vesicles are increasingly being used to detect biomarkers associated with oncology, neurodegenerative diseases, and metabolic disorders. Diagnostic applications lead current market adoption, supported by their ability to provide high-fidelity molecular insights from blood and other biofluids.
Growing Focus on Exosome Therapeutics
Therapeutic applications are gaining strong traction as researchers and biotech innovators engineerexosomes for targeted drug delivery, gene modulation, and regenerative therapies. Advancements in exosome engineering and scalable GMP-grade production are accelerating clinical-pipeline activity, positioning exosomes as a transformative modality in precision medicine.
Regional MarketInsights
North Americaremainsthe largest contributor to the global exosomes market, driven by substantial R&D investments, expanding clinical trials, and strong collaborations between biotechnology companies and academic research centers. The regionbenefitsfrom supportive regulatory pathways and high adoption of advanced biomedical technologies.
Asia-Pacific is projected to record the fastest growth, supported by expanding biotechnology infrastructure, increasing healthcare investments, and government initiatives promoting translational research. Countries such as China, Japan, and South Korea are emerging as high-potential hubs for exosome-based research and manufacturing.
Market Segment Breakdown
By Product Type
— Kits & Reagents
— Instruments
— Services & Software
By Workflow
— Isolation Methods
— Ultracentrifugation
— Immuno-affinity Capture
— Polymer-based Precipitation
— Microfluidic Isolation
— Downstream Analysis
— Nano-flow Cytometry
— Electron Microscopy
— Mass Spectrometry
By Biomolecule Type
— Non-coding RNA (miRNA, lncRNA)
— Proteins & Peptides
— Lipids
— mRNA
— DNA Fragments
By Application
— Diagnostics
— Cancer
— Neuro-degenerative Diseases
— Infectious Diseases
— Therapeutics
— Oncology
— Regenerative Medicine
— Drug Delivery Platforms
By End User
— Pharmaceutical & Biotechnology Companies
— Academic & Research Institutes
— Hospitals & Clinics
— Diagnostic Centers
By Geography
— North America
— Europe
— Asia-Pacific
— Middle East & Africa
— South America
For a full breakdown of market size, segmentation data, and competitive intelligence, access the details of the Mordor Intelligence report:https://www.mordorintelligence.com/industry-reports/exosomes-market?utm_source=prnewswire
Strategic Competitive Environment
The exosomes market is moderately fragmented, with global and emerging players focusing on innovations in exosome isolation technologies, large-scale manufacturing, and therapeutic engineering. Companies are increasingly forming partnerships to advance clinical research,optimizebioinformatics workflows, and develop platform technologies for diagnostics and drug delivery. Strategic collaborations, licensing agreements, and targeted acquisitions continue to shape the competitive landscape as organizations seek to strengthen technological capabilities and broaden application portfolios.
Key Companies Include:
— ThermoFisher Scientific Inc.
— Danaher Corp. (Beckman Coulter)
— Qiagen N.V.
— Lonza Group Ltd
— Fujifilm Holdings Corp.
Check out related reports published by Mordor Intelligence:
Epigenetics Market:Theepigenetics market is segmented by product (instruments, reagents & kits), application (oncology, neurology &CNSdisorders, metabolic diseases, autoimmune diseases), technology (dnamethylation analysis, histone modification-acetylation, methylation), andgeography (North America, Europe, Asia Pacific).
ThermoFisher Scientific, Agilent Technologies, Roche,PerkinElmerand QIAGENare the major companiesoperatingin this market.
Read more about companies active inEpigenetics:https://www.mordorintelligence.com/industry-reports/epigenetics-market/companies?utm_source=prnewswire
In Situ Hybridization Market:Thein situhybridization market is segmented by product (analytical instruments, probes kits & reagents), technique (fluorescence ISH), application (cancer diagnostics & research, infectious diseases), end user (diagnostic laboratories), andgeography (North America, Europe, Asia-Pacific, Middle East & Africa, South America).
Roche,GenemedBiotechnologies, Agilent Technologies,BiocareMedical andThermoFisher Scientificare the major companiesoperatingin this market.
Read more about companies active inIn Situ Hybridization:https://www.mordorintelligence.com/industry-reports/in-situ-hybridization-market/companies?utm_source=prnewswire
Consumer Genomics Market:Theconsumer genomics market is segmented by application (genetic relatedness, diagnostics), technology (microarray genotyping,SNPgenotyping), sample type (saliva, buccal swab), distribution channel (direct-to-consumer, physician-mediated & clinics), andgeography (North America, Europe, Asia-Pacific, and More).
23andMe, Ancestry, Positive Bioscience, Futura Genetics and HelixOpCoare the major companiesoperatingin this market.
Read more about companies active inConsumer Genomics:
https://www.mordorintelligence.com/industry-reports/consumer-genomics-market–growth-trends-and-forecast/companies?utm_source=prnewswire
About MordorIntelligence:Mordor Intelligence is a trusted partner for businessesseekingcomprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligencepossessesa unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries, please contact: media@mordorintelligence.com https://www.mordorintelligence.com/contact-us
Logo: https://mma.prnewswire.com/media/2746908/Mordor_Intelligence_Logo.jpg
https://edge.prnewswire.com/c/img/favicon.png?sn=IO41236&sd=2025-12-08
View original content:https://www.prnewswire.com/news-releases/exosomes-market-led-by-north-america-with-53-revenue-share-and-global-market-size-set-to-surpass-usd-2b-by-2030-says-mordor-intelligence-302635159.html
SOURCE Mordor Intelligence Private Limited
https://rt.newswire.ca/rt.gif?NewsItemId=IO41236&Transmission_Id=202512080535PR_NEWS_USPR_____IO41236&DateId=20251208